Close

Allergan Generics (AGN), Teva Pharma (TEVA) Deal has $2.5B Termination Fee

July 28, 2015 9:14 AM EDT Send to a Friend
Allergan (NYSE: AGN) disclosed the following in an 8-K filed with the U.S. SEC on Tuesday morning:Allergan plc, a public ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login